Perinatal antibiotic exposure of neonates in Canada and associated risk factors: A population-based study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 10, 2015, Pages 1190-1195

  Persaud, Ryan R ^a   Azad, Meghan B ^b   Chari, Radha S ^c   Sears, Malcolm R ^d   Becker, Allan B ^a   Kozyrskyj, Anita L ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Antibiotic; intrapartum; neonate; overweight; prophylaxis

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFAZOLIN; CEFOXITIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; PSEUDOMONIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CANADA; CESAREAN SECTION; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HEALTH STATUS; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN SEPSIS; OBESITY; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PRESCRIPTION; PREVALENCE; PRIMIGRAVIDA; PRIORITY JOURNAL; RISK FACTOR; ADULT; CHEMICALLY INDUCED; INFANT; LONGITUDINAL STUDY; NEWBORN DISEASE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE; RETROSPECTIVE STUDY;

ADULT; ANTI-BACTERIAL AGENTS; CANADA; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84940646128     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.947578     Document Type: Article

References (30)

1. Health Indicators Interactive Tool [Internet]. Ottawa, ON: Canadian Institute for Health Research; 2011. Available from: http:// www.cihi.ca/hirpt/search.jspa [last accessed 27 May 2014].
2. Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006;4:932-42.
3. Schalkwyk J, Eyk N. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Canada 2010;32:878-92.
4. Heaman M, Kingston D, Helewa ME, et al. Perinatal services and outcomes in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy; November 2012.
5. Money DM, Dobson S. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Canada 2004;26: 826-40.
6. Konrad G, Hauch S, Pylypjuk C. Prevention of neonatal group B streptococcal infection: approaches of physicians in Winnipeg, Man. Can Fam Physician 2007;53:290, 289:e.1-5, 289.
7. Flenady V, King J. Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev 2002;(3):CD001807.
8. Barrington K. Management of the infant at increased risk for sepsis. Paediatr Child Health 2007;12:893-8.
9. Penders J, Kummeling I, Thijs C. Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis. Eur Resp J 2011;38:295-302.
10. Penders J, Thijs C, Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007;56:661-7.
11. Fouhy F, Guinane C, Hussey S, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012;56:5811-20.
12. Favier CF, de Vos WM, Akkermans ADL. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe 2003;9:219-29.
13. Canadian Guidelines for Body Weight Classification in Adults [Internet]. Ottawa, ON: Health Canada; 2003. Available from: http://www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/ bmi-chart-java-graph-imc-java-eng.php [last accessed 27 May 2014].
14. Bar-Oz B, Bulkowstein M, Benyamini L, et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf 2003;26:925-35.
15. Yoshioka H, Cho K, Takimoto M, et al. Transfer of cefazolin into human milk. J Pediatr 1979;94:151-2.
16. Charles D. Placental transmission of antibiotics. J Obstet Gynaecol Br Emp 1954;61:750-7.
17. McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease. Am J Resp Crit Care Med 2002;166:827-32.
18. Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 2013;121:570-7.
19. Mahieu LM, Dooy JJ, Leys E. Obstetricians' compliance with CDC guidelines on maternal screening and intrapartum prophylaxis for group B streptococcus. J Obstet Gynaecol 2000;20:460-4.
20. Hughes RG, Brocklehurst P, Heath P, Stenson B. The prevention of early-onset neonatal group B Streptococcal disease. RCOG Green-Top Guideline No. 36. 2nd ed. London: Royal College of Obstetricians and Gynaecologists; 2012:1-13.
21. Stokholm J, Schjørring S, Pedersen L, et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PloS One 2013;8:e82932.
22. Alfirevic Z, Gyte G, Dou L. Different classes of antibiotics given to women routinely for preventing infection at caesarean section (Review). Cochrane Database Syst Rev 2010;6:CD008726.
23. American College of Obstetricians and Gynecologists. Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2011; 117:1472-83.
24. Doss AE, Davidson JD, Cliver SP, et al. Antibiotic prophylaxis for cesarean delivery: survey of maternal-fetal medicine physicians in the U.S. J Matern Fetal Neonatal Med 2012;25:1264-6.
25. Raghunathan K, Connelly NR, Friderici J, et al. Unwarranted variability in antibiotic prophylaxis for cesarean section delivery: a national survey of anesthesiologists. Anesth Analg 2013;116: 644-8.
26. Alm B, Erdes L, Möllborg P, et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008;121:697-702.
27. Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and early-life body mass. Int J Obes 2013;37:16-23.
28. Ajslev TA, Andersen CS, Gamborg M, et al. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 2011;35:522-9.
29. Minassian C, Thomas SL, Williams DJ, et al. Acute maternal infection and risk of pre-eclampsia: a population-based case-control study. PLoS One 2013;8:e73047.
30. Sebastián Manzanares G, Angel Santalla H, Irene Vico Z, et al. Abnormal maternal body mass index and obstetric and neonatal outcome. J Matern Fetal Neonatal Med 2012;25:308-12.